Work

RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of traditional cytotoxic agents in breast cancer cells.

Year: 2007

Type: article

Source: Molecular Cancer Therapeutics

Authors: Scott E. Martin, Yves Pommier, Natasha J. Caplen

Institution: National Cancer Institute

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2267428007

FWCI:

Cites:

Cited by: 2

Related to: 20